Aging
Navigate
Submit an Article
Research Paper|Volume 15, Issue 15|pp. 7831–7843
Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma
Back to articleFigure 1(1 of 9)
100%
Figure 1
Figure 1.Venn diagram of drug-disease intersection target.
Figure 1 — Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma | Aging